According to a newly published market research report by 24LifeSciences, global Carcinoembryonic Antigen (CEA) market was valued at USD 1.73 billion in 2024 and is projected to reach USD 2.33 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.4% during the forecast period 20252031. Carcinoembryonic antigen (CEA), a critical glycoprotein biomarker, plays an essential role in...